Recent analysis from the SHINE trial has found a link between high blood sugar after thrombolysis and life-threatening brain bleeds, especially in patients with severe strokes.
Author: Megan Davis
Researchers believe understanding mutations in ER protein translocation and processing complexes will lead to improved treatments for patients with congenital disorders of glycosylation.
UVA Health's Pituitary Tumor Program ensures optimal patient outcomes through collaboration, cutting-edge techniques, and streamlined care pathways.
UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
Researchers in the Sontheimer lab study ways to slow memory loss in diseases like Alzheimer's by reducing inflammation in the brain.
Learn how her research could lead to new and better life-saving treatments for ovarian and pancreatic cancers.
In his work as a UVA Health orthopedic surgeon and researcher, Brian Werner, MD, says his biggest passion is "making patients better." "I love watching them recover from surgery and get back to their regular lives and what they love doing," he explains. To that end, Werner's research focuses on…
The Fragility Fracture and Bone Health Clinic at UVA Health establishes a pathway for patients at risk for devastating fractures.
Learn how our orthopedic surgeons treat these injuries, which are on the rise in young athletes.